• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫利用补体受体 1 的关键功能部位入侵人红细胞。

Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.

机构信息

Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

出版信息

Blood. 2011 Aug 18;118(7):1923-33. doi: 10.1182/blood-2011-03-341305. Epub 2011 Jun 17.

DOI:10.1182/blood-2011-03-341305
PMID:21685372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3158720/
Abstract

The Plasmodium falciparum adhesin PfRh4 binds to complement receptor type-1 (CR1) on human erythrocytes and mediates a glycophorin-independent invasion pathway. CR1 is a complement regulator and immune-adherence receptor on erythrocytes required for shuttling of C3b/C4b-opsonized particles to liver and spleen for phagocytosis. Using recombinant CR1 constructs, we mapped the recognition site for PfRh4 to complement control protein modules 1 to 3 (CCP1-3) at the membrane-distal amino terminus of CR1. This region of CR1 binds to C4b and C3b and accelerates decay of both classic pathway and alternative pathway C3 and C5 convertases. CCP1-3 competed for PfRh4 binding to erythroid CR1 and inhibited the PfRh4-CR1 invasion pathways across a wide range of P falciparum strains. PfRh4 did not bind significantly to other CR1 constructs, including CCP15-17, which is 85% identical to CCP1-3. PfRh4 binding to CR1 did not affect its C3b/C4b binding capability, and we show evidence for a ternary complex between CCP1-3, C4b, and PfRh4. PfRh4 binding specifically inhibited CR1's convertase decay-accelerating activity, whereas there was no effect on factor H-mediated decay-accelerating activity. These results increase our understanding of the functional implications of CR1 engagement with PfRh4 and highlight the interplay between complement regulation and infection.

摘要

恶性疟原虫黏附素 PfRh4 与人红细胞补体受体 1(CR1)结合,并介导一种非糖蛋白依赖的入侵途径。CR1 是红细胞上的补体调节蛋白和免疫黏附受体,对于将 C3b/C4b 包被的颗粒运送到肝脏和脾脏进行吞噬至关重要。使用重组 CR1 构建体,我们将 PfRh4 的识别位点定位到 CR1 膜远端氨基末端的补体控制蛋白模块 1 到 3(CCP1-3)。该 CR1 区域与 C4b 和 C3b 结合,并加速经典途径和替代途径 C3 和 C5 转化酶的衰变。CCP1-3 与 PfRh4 竞争与红细胞 CR1 的结合,并抑制 PfRh4-CR1 入侵途径在广泛的恶性疟原虫株中。PfRh4 与其他 CR1 构建体(包括与 CCP1-3 有 85%相同的 CCP15-17)结合不显著。PfRh4 与 CR1 的结合并不影响其 C3b/C4b 结合能力,并且我们证明了 CCP1-3、C4b 和 PfRh4 之间存在三元复合物。PfRh4 结合特异性抑制 CR1 的转化酶衰变加速活性,而对因子 H 介导的衰变加速活性没有影响。这些结果增加了我们对 CR1 与 PfRh4 结合的功能意义的理解,并强调了补体调节与感染之间的相互作用。

相似文献

1
Plasmodium falciparum uses a key functional site in complement receptor type-1 for invasion of human erythrocytes.恶性疟原虫利用补体受体 1 的关键功能部位入侵人红细胞。
Blood. 2011 Aug 18;118(7):1923-33. doi: 10.1182/blood-2011-03-341305. Epub 2011 Jun 17.
2
Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.利用诱变和结构生物学绘制恶性疟原虫裂殖子蛋白 PfRh4 与人免疫黏附受体结合位点的图谱。
J Biol Chem. 2014 Jan 3;289(1):450-63. doi: 10.1074/jbc.M113.520346. Epub 2013 Nov 8.
3
Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand.补体受体 1 是恶性疟原虫 PfRh4 入侵配体的宿主红细胞受体。
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17327-32. doi: 10.1073/pnas.1008151107. Epub 2010 Sep 20.
4
Characterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1.调节恶性疟原虫粘附素PfRh4与其红细胞受体补体受体1之间相互作用的抑制剂和单克隆抗体的特性分析
J Biol Chem. 2015 Oct 16;290(42):25307-21. doi: 10.1074/jbc.M115.657171. Epub 2015 Aug 31.
5
Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes.恶性疟原虫野外分离株利用补体受体1(CR1)作为侵入红细胞的受体。
Mol Biochem Parasitol. 2011 May;177(1):57-60. doi: 10.1016/j.molbiopara.2011.01.005. Epub 2011 Jan 18.
6
Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion.重组恶性疟原虫网织红细胞同源蛋白4与红细胞结合并阻断入侵。
Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17789-94. doi: 10.1073/pnas.0708772104. Epub 2007 Oct 30.
7
The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria.恶性疟原虫红细胞入侵配体 Pfrh4 作为功能性和保护性人抗疟疾抗体的靶标。
PLoS One. 2012;7(9):e45253. doi: 10.1371/journal.pone.0045253. Epub 2012 Sep 20.
8
Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum.补体受体 1 是恶性疟原虫红细胞的非唾液酸依赖受体。
PLoS Pathog. 2010 Jun 17;6(6):e1000968. doi: 10.1371/journal.ppat.1000968.
9
Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes.抗网织红细胞结合蛋白样同源物4抗体可抑制恶性疟原虫侵入人红细胞。
Infect Immun. 2009 Jun;77(6):2427-35. doi: 10.1128/IAI.00048-09. Epub 2009 Mar 23.
10
Complement receptor is an inhibitor of the complement cascade.补体受体是补体级联反应的一种抑制剂。
J Exp Med. 1981 May 1;153(5):1138-50. doi: 10.1084/jem.153.5.1138.

引用本文的文献

1
A novel and rapid method to purify the human complement opsonin C3b from human plasma.一种从人血浆中纯化人补体调理素C3b的新颖快速方法。
Front Immunol. 2025 Aug 26;16:1639735. doi: 10.3389/fimmu.2025.1639735. eCollection 2025.
2
Deposition of complement regulators on the surface of Plasmodium falciparum merozoites depends on the immune status of the host.补体调节蛋白在恶性疟原虫裂殖子表面的沉积取决于宿主的免疫状态。
PLoS Pathog. 2025 Apr 28;21(4):e1013107. doi: 10.1371/journal.ppat.1013107. eCollection 2025 Apr.
3
Determining Ligand Binding and Specificity Within the β-Integrin Family with a Novel Assay Platform.利用新型检测平台确定β-整合素家族内的配体结合与特异性
Biomolecules. 2025 Feb 7;15(2):238. doi: 10.3390/biom15020238.
4
Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways.三融合蛋白(TriFu):一种对所有三种补体激活途径均有效的、靶向性的、类似酶的抑制剂。
J Biol Chem. 2024 Apr;300(4):105784. doi: 10.1016/j.jbc.2024.105784. Epub 2024 Feb 23.
5
Complement receptor 1 is the human erythrocyte receptor for erythrocyte binding protein.补体受体 1 是人类红细胞的红细胞结合蛋白受体。
Proc Natl Acad Sci U S A. 2024 Jan 30;121(5):e2316304121. doi: 10.1073/pnas.2316304121. Epub 2024 Jan 23.
6
Population-specific positive selection on low CR1 expression in malaria-endemic regions.疟疾流行地区低 CR1 表达的人群特异性正选择。
PLoS One. 2023 Jan 10;18(1):e0280282. doi: 10.1371/journal.pone.0280282. eCollection 2023.
7
Epigenetic and Epitranscriptomic Gene Regulation in and How We Can Use It against Malaria.和中的表观遗传和转录后基因调控以及我们如何利用它来对抗疟疾。
Genes (Basel). 2022 Sep 27;13(10):1734. doi: 10.3390/genes13101734.
8
The Cellular and Molecular Interaction Between Erythrocytes and Merozoites.红细胞与裂殖子之间的细胞和分子相互作用
Front Cell Infect Microbiol. 2022 Mar 31;12:816574. doi: 10.3389/fcimb.2022.816574. eCollection 2022.
9
A novel soluble complement receptor 1 fragment with enhanced therapeutic potential.一种新型可溶性补体受体 1 片段,具有增强的治疗潜力。
J Biol Chem. 2021 Jan-Jun;296:100200. doi: 10.1074/jbc.RA120.016127. Epub 2020 Dec 23.
10
Few Plasmodium falciparum merozoite ligand and erythrocyte receptor pairs show evidence of balancing selection.很少有恶性疟原虫裂殖子配体和红细胞受体对显示出平衡选择的证据。
Infect Genet Evol. 2019 Apr;69:235-245. doi: 10.1016/j.meegid.2019.02.004. Epub 2019 Feb 5.

本文引用的文献

1
Plasmodium falciparum field isolates use complement receptor 1 (CR1) as a receptor for invasion of erythrocytes.恶性疟原虫野外分离株利用补体受体1(CR1)作为侵入红细胞的受体。
Mol Biochem Parasitol. 2011 May;177(1):57-60. doi: 10.1016/j.molbiopara.2011.01.005. Epub 2011 Jan 18.
2
Production of biologically active complement factor H in therapeutically useful quantities.以治疗有效量生产生物活性补体因子H。
Protein Expr Purif. 2011 Apr;76(2):254-63. doi: 10.1016/j.pep.2010.12.002. Epub 2010 Dec 10.
3
Ligation of complement receptor 1 increases erythrocyte membrane deformability.补体受体 1 的交联可增加红细胞膜的变形性。
Blood. 2010 Dec 23;116(26):6063-71. doi: 10.1182/blood-2010-04-273904. Epub 2010 Sep 22.
4
Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand.补体受体 1 是恶性疟原虫 PfRh4 入侵配体的宿主红细胞受体。
Proc Natl Acad Sci U S A. 2010 Oct 5;107(40):17327-32. doi: 10.1073/pnas.1008151107. Epub 2010 Sep 20.
5
Complement receptor 1 is a sialic acid-independent erythrocyte receptor of Plasmodium falciparum.补体受体 1 是恶性疟原虫红细胞的非唾液酸依赖受体。
PLoS Pathog. 2010 Jun 17;6(6):e1000968. doi: 10.1371/journal.ppat.1000968.
6
Erythrocyte invasion and merozoite ligand gene expression in severe and mild Plasmodium falciparum malaria.严重和轻度恶性疟原虫疟疾中红细胞入侵和裂殖子配体基因表达。
J Infect Dis. 2010 Feb 1;201(3):444-52. doi: 10.1086/649902.
7
Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.补体片段C3b-因子H的结构及其对补体调节因子宿主保护作用的影响
Nat Immunol. 2009 Jul;10(7):728-33. doi: 10.1038/ni.1755. Epub 2009 Jun 7.
8
Antibodies to reticulocyte binding protein-like homologue 4 inhibit invasion of Plasmodium falciparum into human erythrocytes.抗网织红细胞结合蛋白样同源物4抗体可抑制恶性疟原虫侵入人红细胞。
Infect Immun. 2009 Jun;77(6):2427-35. doi: 10.1128/IAI.00048-09. Epub 2009 Mar 23.
9
Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1.血型糖蛋白B是恶性疟原虫红细胞结合配体EBL-1的红细胞受体。
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5348-52. doi: 10.1073/pnas.0900878106. Epub 2009 Mar 11.
10
Polymorphisms in erythrocyte binding antigens 140 and 181 affect function and binding but not receptor specificity in Plasmodium falciparum.恶性疟原虫红细胞结合抗原140和181中的多态性影响其功能和结合,但不影响受体特异性。
Infect Immun. 2009 Apr;77(4):1689-99. doi: 10.1128/IAI.01331-08. Epub 2009 Feb 9.